Safety of the Breast Cancer Adjuvant Radiotherapy in Ataxia-Telangiectasia Mutated Variant Carriers.

Autor: Bensenane R; Department of Radiation Oncology, Institut Curie, 75248 Paris, France., Beddok A; Department of Radiation Oncology, Institut Godinot, 51454 Reims, France.; CRESTIC EA 3804, University Reims Champagne-Ardenne, 51454 Reims, France., Lesueur F; Inserm U900, Institut Curie, PSL Research University, Mines ParisTech, 75248 Paris, France., Fourquet A; Department of Radiation Oncology, Institut Curie, 75248 Paris, France., Warcoin M; Department of Genetics, Institut Curie, 75248 Paris, France.; Inserm U830, Institut Curie, Paris-Cité University, 75248 Paris, France.; Paris Sciences & Lettres Research University, 75248 Paris, France., Le Mentec M; Department of Genetics, Institut Curie, 75248 Paris, France.; Inserm U830, Institut Curie, Paris-Cité University, 75248 Paris, France.; Paris Sciences & Lettres Research University, 75248 Paris, France., Cavaciuti E; Inserm U900, Institut Curie, PSL Research University, Mines ParisTech, 75248 Paris, France., Le Gal D; Inserm U900, Institut Curie, PSL Research University, Mines ParisTech, 75248 Paris, France., Eon-Marchais S; Inserm U900, Institut Curie, PSL Research University, Mines ParisTech, 75248 Paris, France., Andrieu N; Inserm U900, Institut Curie, PSL Research University, Mines ParisTech, 75248 Paris, France., Stoppa-Lyonnet D; Department of Genetics, Institut Curie, 75248 Paris, France.; Inserm U830, Institut Curie, Paris-Cité University, 75248 Paris, France., Kirova Y; Department of Radiation Oncology, Institut Curie, 75248 Paris, France.; University Versailles, 02100 St. Quentin, France.

Publikováno v: Cancers [Cancers (Basel)] 2024 Apr 05; Vol. 16 (7). Date of Electronic Publication: 2024 Apr 05.

Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation.

Autor: Ribeiro Guerra M; INSERM, U900, Paris, France.; Institut Curie, Paris, France.; Mines ParisTech, Fontainebleau, France.; PSL Research University, Paris, France.; Department of Public Health, Faculty of Medicine, Federal University of Juiz de Fora - UFJF, Minas Gerais, Brazil., Coignard J; INSERM, U900, Paris, France.; Institut Curie, Paris, France.; Mines ParisTech, Fontainebleau, France.; PSL Research University, Paris, France., Eon-Marchais S; INSERM, U900, Paris, France.; Institut Curie, Paris, France.; Mines ParisTech, Fontainebleau, France.; PSL Research University, Paris, France., Dondon MG; INSERM, U900, Paris, France.; Institut Curie, Paris, France.; Mines ParisTech, Fontainebleau, France.; PSL Research University, Paris, France., Le Gal D; INSERM, U900, Paris, France.; Institut Curie, Paris, France.; Mines ParisTech, Fontainebleau, France.; PSL Research University, Paris, France., Beauvallet J; INSERM, U900, Paris, France.; Institut Curie, Paris, France.; Mines ParisTech, Fontainebleau, France.; PSL Research University, Paris, France., Mebirouk N; INSERM, U900, Paris, France.; Institut Curie, Paris, France.; Mines ParisTech, Fontainebleau, France.; PSL Research University, Paris, France., Belotti M; Institut Curie, Service de Génétique, Paris, France., Caron O; Gustave Roussy, Département de Médecine Oncologique, Université Paris-Saclay, Villejuif, France., Gauthier-Villars M; Institut Curie, Service de Génétique, Paris, France., Coupier I; Hôpital Arnaud de Villeneuve, CHU Montpellier, Service de Génétique Médicale et Oncogénétique, Montpellier, France.; INSERM 896, CRCM Val d'Aurelle, Montpellier, France., Buecher B; Institut Curie, Service de Génétique, Paris, France., Lortholary A; Centre Catherine de Sienne, Service d'Oncologie Médicale, Nantes, France., Fricker JP; Centre Paul Strauss, Unité d'Oncologie, Strasbourg, France., Gesta P; CH Georges Renon, Service d'Oncogénétique Régional Poitou-Charentes, Niort, France., Noguès C; Département d'Anticipation et de Suivi des Cancers, Oncogénétique Clinique, Institut Paoli Calmettes, Marseille, France.; Aix Marseille Univ, INSERM, IRD, SESSTIM, Marseille, France., Faivre L; Institut GIMI, CHU de Dijon, Hôpital d'Enfants, Dijon, France.; Centre de Lutte contre le Cancer Georges François Leclerc, Dijon, France., Berthet P; Centre François Baclesse, Unité de pathologie gynécologique, Caen, France., Luporsi E; Service de Génétique UF4128 CHR Metz-Thionville, Hôpital de Mercy, Metz, France., Delnatte C; Centre René Gauducheau, Unité d'Oncogénétique, Nantes, Saint Herblain, France., Bonadona V; Université Claude Bernard Lyon 1, Villeurbanne, France.; CNRS UMR 5558, Lyon, France.; Centre Léon Bérard, Unité de Prévention et Epidémiologie Génétique, Lyon, France., Maugard CM; Génétique Oncologique moléculaire, UF1422, Département d'Oncobiologie, LBBM, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.; UF6948 Génétique Oncologique Clinique, Evaluation familiale et suivi, Hôpitaux Universitaires de Strasbourg, Strasbourg, France., Pujol P; Hôpital Arnaud de Villeneuve, CHU Montpellier, Service de Génétique Médicale et Oncogénétique, Montpellier, France.; INSERM 896, CRCM Val d'Aurelle, Montpellier, France., Lasset C; Université Claude Bernard Lyon 1, Villeurbanne, France.; CNRS UMR 5558, Lyon, France.; Centre Léon Bérard, Unité de Prévention et Epidémiologie Génétique, Lyon, France., Longy M; Institut Bergonié, Bordeaux, France., Bignon YJ; Département d'oncogénétique, Centre Jean Perrin, Université Clermont Auvergne, UMR INSERM 1240, Clermont Ferrand, France., Adenis-Lavignasse C; Polyclinique de la Louvière (groupe Ramsay), Lille, France., Venat-Bouvet L; Service d'Oncologie Médicale, Hôpital Universitaire Dupuytren, Limoges, France., Dreyfus H; Clinique Sainte Catherine, Avignon, France.; Hôpital Couple-Enfant, Département de Génétique, CHU de Grenoble, Grenoble, France., Gladieff L; Institut Claudius Regaud - IUCT-Oncopole, Service d'Oncologie Médicale, Toulouse, France., Mortemousque I; Service de Génétique, Hôpital Bretonneau, Tours, France., Audebert-Bellanger S; Département de Génétique Médicale et Biologie de la Reproduction, Hôpital Morvan, CHU Brest, Brest, France., Soubrier F; Hôpital Tenon, Paris, France., Giraud S; Hospices Civils de Lyon, Service de Génétique, Groupement Hospitalier EST, Bron, France., Lejeune-Dumoulin S; Clinique de Génétique Médicale Guy Fontaine, CHU Lille, Lille, France., Limacher JM; Service d'Onco-hématologie, Hôpital Pasteur, Colmar, France., Chiesa J; Service d'Oncologie Médicale, CHRU Hôpital Caremeau, Nîmes, France., Fajac A; Service d'Oncogénétique, Hôpital Tenon, Paris, France., Floquet A; Institut Bergonié, Bordeaux, France., Eisinger F; Département d'Anticipation et de Suivi des Cancers, Oncogénétique Clinique, Institut Paoli Calmettes, Marseille, France.; Aix Marseille Univ, INSERM, IRD, SESSTIM, Marseille, France., Tinat J; Groupe Hospitalier Pellegrin, Service de génétique médicale, CHU De Bordeaux, Bordeaux, France., Fert-Ferrer S; Centre Hospitalier Métropole Savoie, Chambéry, France., Colas C; Institut Curie, Service de Génétique, Paris, France.; Institut Curie, Hopital René Huguenin, Saint-Cloud, France., Frebourg T; Département de Génétique, Hopital Universitaire de Rouen, Rouen, France., Damiola F; Department of Biopathology, Pathology Research platform, Centre Léon Bérard, Lyon, France., Barjhoux L; GCS AURAGEN, Plateforme de Génétique, Hôpital Edouart Herriot, Lyon, France., Cavaciuti E; INSERM, U900, Paris, France.; Institut Curie, Paris, France.; Mines ParisTech, Fontainebleau, France.; PSL Research University, Paris, France., Mazoyer S; Centre de Recherche en Neurosciences de Lyon, INSERM U1028, CNRS UMR5292, Université Lyon 1, Université Saint Etienne, Lyon, France., Tardivon A; Service de Radiologie, Institut Curie, Paris, France., Lesueur F; INSERM, U900, Paris, France.; Institut Curie, Paris, France.; Mines ParisTech, Fontainebleau, France.; PSL Research University, Paris, France., Stoppa-Lyonnet D; Institut Curie, Service de Génétique, Paris, France.; INSERM, U830, Paris, France.; Université Paris-Descartes, Paris, France., Andrieu N; INSERM, U900, Paris, France. nadine.andrieu@curie.fr.; Institut Curie, Paris, France. nadine.andrieu@curie.fr.; Mines ParisTech, Fontainebleau, France. nadine.andrieu@curie.fr.; PSL Research University, Paris, France. nadine.andrieu@curie.fr.

Publikováno v: Breast cancer research : BCR [Breast Cancer Res] 2021 Aug 03; Vol. 23 (1), pp. 79. Date of Electronic Publication: 2021 Aug 03.

TUMOSPEC: A Nation-Wide Study of Hereditary Breast and Ovarian Cancer Families with a Predicted Pathogenic Variant Identified through Multigene Panel Testing.

Autor: Lesueur F; Inserm, U900, Institut Curie, PSL Research University, Mines ParisTech, F-75005 Paris, France., Eon-Marchais S; Inserm, U900, Institut Curie, PSL Research University, Mines ParisTech, F-75005 Paris, France., Bonnet-Boissinot S; Inserm, U900, Institut Curie, PSL Research University, Mines ParisTech, F-75005 Paris, France., Beauvallet J; Inserm, U900, Institut Curie, PSL Research University, Mines ParisTech, F-75005 Paris, France., Dondon MG; Inserm, U900, Institut Curie, PSL Research University, Mines ParisTech, F-75005 Paris, France., Golmard L; Service de Génétique, Institut Curie, F-75005 Paris, France., Rouleau E; Service de Génétique, Département de Biologie et Pathologie Médicales, Gustave Roussy, F-94805 Villejuif, France., Garrec C; Laboratoire Génétique Moléculaire, Institut de Biologie, CHU Hôtel Dieu, F-44093 Nantes, France., Martinez M; Unité de Génétique Clinique, CHU Rouen Normandie, F-76100 Rouen, France., Toulas C; Laboratoire d'Oncogénétique, Institut Claudius Regaud, IUCT-Oncopole, F-31100 Toulouse, France., Nguyen TD; Institut de Cancérologie Jean Godinot, F-51100 Reims, France., Brayotel F; Institut de Cancérologie Jean Godinot, F-51100 Reims, France., Crivelli L; Service d'Oncogénétique, Centre Eugène Marquis, F-35000 Rennes, France., Maugard CM; Centre Paul Strauss, Unité d'Oncogénétique, ICANS Institut de Cancérologie de Strasbourg, F-67200 Strasbourg, France., Bubien V; Unité d'Oncogénétique, Département de Bio-Pathologie, Institut Bergonié, F-33000 Bordeaux, France., Sevenet N; Institut Bergonié, UFR des Sciences Pharmaceutiques, Collège des Sciences de la Santé Université de Bordeaux, INSERM U1218, F-33000 Bordeaux, France., Gesta P; CH Georges Renon, Service d'Oncogénétique Régional Poitou-Charentes, F-79000 Niort, France., Chieze-Valero S; CH Georges Renon, Service d'Oncogénétique Régional Poitou-Charentes, F-79000 Niort, France., Nambot S; Institut GIMI, CHU de Dijon, Hôpital d'Enfants, F-21000 Dijon, France., Goussot V; Unité de Biologie Moléculaire, Département de Biologie et Pathologie des Tumeurs, Centre Georges François Leclerc, F-21000 Dijon, France., Mari V; Service d'Oncogénétique et Recherche Clinique, Centre Antoine Lacassagne, F-06100 Nice, France., Popovici C; Département d'Anticipation et de Suivi des Cancers, Oncogénétique Clinique, Institut Paoli-Calmettes, F-13009 Marseille, France., Prieur F; Service de Génétique, CHU-Hôpital Nord, F-42055 Saint Etienne, France., Morin-Meschin ME; Service d'Oncogénétique, Institut de Cancérologie de l'Ouest, Site Paul Papin, F-49055 Angers, France., Tinat J; Génétique Médicale, CHU de Bordeaux, F-33000 Bordeaux, France., Lortholary A; Service d'Oncologie Médicale, Centre Catherine de Sienne, Hôpital Privé du Confluent, F-44200 Nantes, France., Dreyfus H; Clinique Sainte Catherine, F-84000 Avignon, France.; Département de Génétique, Hôpital Couple-Enfant, CHU de Grenoble, F-38700 Grenoble, France., Bidart M; Laboratoire de Génétique Moléculaire: Maladies Rares et Oncologies, Institut de Biologie et Pathologie, CHU Grenoble Alpes, F-38700 Grenoble, France., Collonge-Rame MA; Consultation d'Oncogénétique, Oncobiologie Génétique Bioinformatique, CHRU, F-25000 Besançon, France., Mozelle-Nivoix M; Centre Hospitalier de Troyes, Hôpital S. Veil, F-10000 Troyes, France., Gladieff L; Service d'Oncologie Médicale, Institut Claudius Regaud-IUCT-Oncopole, F-31100 Toulouse, France., Giraud S; Hospices Civils de Lyon, Service de Génétique, Groupement Hospitalier EST, F-69500 Bron, France., Boutry-Kryza N; Hospices Civils de Lyon, Service de Génétique, Groupement Hospitalier EST, F-69500 Bron, France., Chiesa J; UF de Cytogénétique et Génétique Médicale, CHRU Hôpital Caremeau, F-30900 Nîmes, France., Denizeau P; Service de Génétique Clinique, Hôpital Sud, F-35200 Rennes, France., Bignon YJ; Centre Jean Perrin, Département d'Oncogénétique, Université Clermont Auvergne, UMR INSERM 1240, F-63011 Clermont Ferrand, France., Uhrhammer N; Centre Jean Perrin, LBM OncoGenAuvergne, F-63011 Clermont Ferrand, France., Cohen-Haguenauer O; Unité d'Oncogénétique Clinique AP-HP Nord-UP, DMU Icare, UFR de Médecine de l'Université de Paris, INSERM UMR-S 976, Hôpital Saint-Louis, F-75010 Paris, France., Vilquin P; Département de Génomique des Tumeurs Solides, Hôpital Saint-Louis, APHP, F-75010 Paris, France., Mailliez A; Centre Oscar Lambret, F-59000 Lille, France., Coupier I; Service de Génétique Médicale et Oncogénétique, Hôpital Arnaud de Villeneuve, CHU Montpellier, F-34090 Montpellier, France.; INSERM 896, CRCM Val d'Aurelle, F-34090 Montpellier, France., Rey JM; Laboratoire de Biopathologie Cellulaire et Tissulaire des Tumeurs, CHRU Arnaud de Villeneuve, F-34090 Montpellier, France., Lacaze E; Unité de Génétique Médicale, Groupe Hospitalier du Havre, F-76290 Le Havre, France., Béra O; CHU de Martinique, F-97261 Fort-de-France, France., Colas C; Service de Génétique, Institut Curie, F-75005 Paris, France., Coulet F; Service de Génétique, AP-HP, Hôpital Universitaire Pitié-Salpétrière, F-75013 Paris, France., Delnatte C; Unité d'Oncogénétique, ICO-Site René Gauducheau, F-44800 Nantes Saint Herblain, France., Houdayer C; Département de Génétique, Hôpital Universitaire de Rouen, Unirouen, Inserm U1245, F-76000 Rouen, France., Lasset C; CNRS UMR 5558, Université Claude Bernard Lyon 1, F-69100 Villeurbanne, France.; Centre Léon Bérard, Unité de Prévention et Epidémiologie Génétique, F-69008 Lyon, France., Lemonnier J; R&D UNICANCER, Fédération Nationale des Centres de Lutte Contre le Cancer, F-75013 Paris, France., Longy M; Cancer Genetics Unit & INSERM U1218, Institut Bergonié, University of Bordeaux, F-33000 Bordeaux, France., Noguès C; Département d'Anticipation et de Suivi des Cancers, Oncogénétique Clinique, Institut Paoli-Calmettes, F-13009 Marseille, France.; Institut Paoli-Calmettes & Aix Marseille University, INSERM, IRD, SESSTIM, F-13009 Marseille, France., Stoppa-Lyonnet D; Service de Génétique, Institut Curie, F-75005 Paris, France.; Inserm, U830, Université de Paris, F-75005 Paris, France., Vaur D; Laboratoire de Biologie et de Génétique du Cancer, Centre François Baclesse, F-14000 Caen, France., Andrieu N; Inserm, U900, Institut Curie, PSL Research University, Mines ParisTech, F-75005 Paris, France., Caron O; Département de Médecine Oncologique, Gustave Roussy, F-94805 Villejuif, France.; Centre Médical de Bligny, F-91640 Briis-Sous-Forges, France.

Publikováno v: Cancers [Cancers (Basel)] 2021 Jul 21; Vol. 13 (15). Date of Electronic Publication: 2021 Jul 21.

Estimating the Number of Polygenic Diseases Among Six Mutually Exclusive Entities of Non-Tumors and Cancer.

Autor: Smith, C. I. Edvard^1,2,3 (AUTHOR) edvard.smith@ki.se, Burger, Jan A.⁴ (AUTHOR) jaburger@mdanderson.org, Zain, Rula^1,2,5 (AUTHOR)

Publikováno v: International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 22, p11968. 23p.

The Spectrum of FANCM Protein Truncating Variants in European Breast Cancer Cases.

Autor: Figlioli G; Genome Diagnostics Program, IFOM - the FIRC Institute for Molecular Oncology, Milan 20139, Italy., Kvist A; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE-22381, Sweden., Tham E; Department of Clinical Genetics, Karolinska University Hospital and Department of Molecular Medicine, Karolinska Institutet, Stockholm 17176, Sweden., Soukupova J; Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague 12853, Czech Republic., Kleiblova P; Institute of Biology and Medical Genetics, General University Hospital and First Faculty of Medicine, Charles University, Prague 12800, Czech Republic., Muranen TA; Department of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, HUS, Helsinki 00029, Finland., Andrieu N; Inserm, U900, Institut Curie, PSL University, Paris F-75005, France.; Mines ParisTech, Fontainebleau F-77300, France., Azzollini J; Department of Medical Oncology and Hematology, Unit of Medical GeneticsFondazione, IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy., Balmaña J; Hereditary Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona 08035, Spain.; Department of Medical Oncology, University Hospital Vall d´Hebron, Barcelona 08035, Spain., Barroso A; Human Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Madrid 28029, Spain., Benítez J; Human Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Madrid 28029, Spain.; Spanish Network on Rare Diseases (CIBERER), Madrid 28029, Spain.; Genotyping Unit, CEGEN, Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Madrid 28029, Spain., Bertelsen B; Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark., Blanco A; Fundación Pública Galega Medicina Xenómica-SERGAS, Santiago de Compostela 15706, Spain.; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela 15706, Spain.; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid 28029, Spain., Bonanni B; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan 20141, Italy., Borg Å; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE-22381, Sweden., Brunet J; Hereditary Cancer Program, Catalan Institute of Oncology, ONCOBELL-IDIBELL-IDIBGI-IGTP, CIBERONC, Barcelona 08908, Spain., Calistri D; Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola 47014, Italy., Calvello M; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan 20141, Italy., Chvojka S; Centre for Medical Genetics and Reproductive Medicine, Gennet, Prague 17000, Czech Republic., Cortesi L; University Modena Hospital, Modena 41124, Italy., Darder E; Hereditary Cancer Program, Catalan Institute of Oncology, ONCOBELL-IDIBELL-IDIBGI-IGTP, CIBERONC, Barcelona 08908, Spain., Del Valle J; Hereditary Cancer Program, Catalan Institute of Oncology, ONCOBELL-IDIBELL-IDIBGI-IGTP, CIBERONC, Barcelona 08908, Spain., Diez O; Hereditary Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona 08035, Spain.; Àrea of Molecular and Clinical Genetics, University Hospital Vall d´Hebron, Barcelona 08035, Spain., Eon-Marchais S; Inserm, U900, Institut Curie, PSL University, Paris F-75005, France.; Mines ParisTech, Fontainebleau F-77300, France., Fostira F; InRASTES, Molecular Diagnostics Laboratory, National Centre for Scientific Research 'Demokritos', Athens 15310, Greece., Gensini F; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence 50134, Italy., Houdayer C; Genetics Department, F76000 and Normandy University, UNIROUEN, Inserm U1245, Normandy Centre for Genomic and Personalized Medicine, Rouen University Hospital, Rouen, France., Janatova M; Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague 12853, Czech Republic., Kiiski JI; Department of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, HUS, Helsinki 00029, Finland., Konstantopoulou I; InRASTES, Molecular Diagnostics Laboratory, National Centre for Scientific Research 'Demokritos', Athens 15310, Greece., Kubelka-Sabit K; Department of Histopathology and Cytology, Clinical Hospital Acibadem Sistina, Skopje 1000, Republic of North Macedonia., Lázaro C; Hereditary Cancer Program, Catalan Institute of Oncology, ONCOBELL-IDIBELL-IDIBGI-IGTP, CIBERONC, Barcelona 08908, Spain., Lesueur F; Inserm, U900, Institut Curie, PSL University, Paris F-75005, France.; Mines ParisTech, Fontainebleau F-77300, France., Manoukian S; Department of Medical Oncology and Hematology, Unit of Medical GeneticsFondazione, IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy., Marcinkute R; Hereditary Cancer Center, Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius 08410, Lithuania., Mickys U; National Center of Pathology, Vilnius University Hospital Santaros Klinikos, Vilnius 08410, Lithuania., Moncoutier V; Service de Génétique, Institut Curie, Inserm, U830, Paris Descartes University, Paris F-75005, France., Myszka A; Institute of Medical Sciences, University of Rzeszow, Rzeszow 35-310, Poland., Nguyen-Dumont T; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton 3168, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne 3010, Australia., Nielsen FC; Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark., Norvilas R; Hereditary Cancer Center, Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius 08410, Lithuania.; Department of experimental, preventive and clinical medicine, State Research Institute Centre for Innovative Medicine, Vilnius 08410, Lithuania., Olah E; Department of Molecular Genetics, National Institute of Oncology, Budapest 1122, Hungary., Osorio A; Human Genetics Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Madrid 28029, Spain.; Spanish Network on Rare Diseases (CIBERER), Madrid 28029, Spain., Papi L; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence 50134, Italy., Peissel B; Department of Medical Oncology and Hematology, Unit of Medical GeneticsFondazione, IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy., Peixoto A; Department of Genetics, Portuguese Oncology Institute of Porto (IPO Porto), Porto 4200-072, Portugal., Plaseska-Karanfilska D; Research Centre for Genetic Engineering and Biotechnology 'Georgi D. Efremov', Macedonian Academy of Sciences and Arts, Skopje 1000, Republic of North Macedonia., Pócza T; Department of Molecular Genetics, National Institute of Oncology, Budapest 1122, Hungary., Rossing M; Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark., Rudaitis V; Department of Gynaecology, Center of Obsterics and Gynaecology, Vilnius University Hospital Santaros Klinikos, Vilnius 08410, Lithuania., Santamariña M; Fundación Pública Galega Medicina Xenómica-SERGAS, Santiago de Compostela 15706, Spain.; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela 15706, Spain.; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid 28029, Spain., Santos C; Department of Genetics, Portuguese Oncology Institute of Porto (IPO Porto), Porto 4200-072, Portugal., Smichkoska S; Medical Faculty, University Clinic of Radiotherapy and Oncology, Ss. Cyril and Methodius University in Skopje, Skopje 1000, Republic of North Macedonia., Southey MC; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton 3168, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne 3010, Australia., Stoppa-Lyonnet D; Service de Génétique, Institut Curie, Inserm, U830, Paris Descartes University, Paris F-75005, France., Teixeira M; Department of Genetics, Portuguese Oncology Institute of Porto (IPO Porto), Porto 4200-072, Portugal.; Biomedical Sciences Institute, University of Porto, Porto 4050-313, Portugal., Törngren T; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE-22381, Sweden., Toss A; University Modena Hospital, Modena 41124, Italy., Urioste M; Familial Cancer Clinical Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Madrid 28029, Spain., Vega A; Fundación Pública Galega Medicina Xenómica-SERGAS, Santiago de Compostela 15706, Spain.; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela 15706, Spain.; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid 28029, Spain., Vlckova Z; Department of Medical Genetics, GHC Genetics, Prague 11000, Czech Republic., Yannoukakos D; InRASTES, Molecular Diagnostics Laboratory, National Centre for Scientific Research 'Demokritos', Athens 15310, Greece., Zampiga V; Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola 47014, Italy., Kleibl Z; Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague 12853, Czech Republic., Radice P; Department of Research, Unit of Molecular Bases of Genetic Risk and Genetic Testing, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy., Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, HUS, Helsinki 00029, Finland., Ehrencrona H; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund SE-22100, Sweden.; Office for Medical Services, Region Skåne, Department of Clinical Genetics and Pathology, Laboratory Medicine, Lund SE-22100, Sweden., Janavicius R; Hereditary Cancer Center, Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius 08410, Lithuania.; Department of experimental, preventive and clinical medicine, State Research Institute Centre for Innovative Medicine, Vilnius 08410, Lithuania., Peterlongo P; Genome Diagnostics Program, IFOM - the FIRC Institute for Molecular Oncology, Milan 20139, Italy.

Publikováno v: Cancers [Cancers (Basel)] 2020 Jan 26; Vol. 12 (2). Date of Electronic Publication: 2020 Jan 26.